COMP and malignant colon neoplasm: The ability to resist chemotherapy drugs is weakened, and the cancer cells with high expression of COMP have stronger proliferation ability, resulting in poor prognosis of patients, which suggests that COMP can be used as a prognostic indicator for colon cancer and provide a new therapeutic target for the treatment of colon cancer (50).